Priority from the Bleeding Disorders PSP
|UNCERTAINTY: When is treatment for immune thrombocytopenic purpura (ITP) required?
|This was one of the 15 questions at the workshop that fell outside of the Top 10. These were not ranked in any order of priority
|JLA question ID
|All the treatments for ITP have some kind of side effects and so should be used only when needed. We do not know at what level of platelet count the benefits outweigh the risks.
|No systematic reviews identified
|Health Research Classification System category
|Extra information provided by this PSP
|Original uncertainty examples
|PSP unique ID
|Total number of uncertainties identified by this PSP.
|66 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
|Date of priority setting workshop
|7 July 2018